Co-Founder and Chief Executive Officer (Interim) @ Fibron
Chris Behrenbruch's Education
University of Oxford
Ph.D (D.Phil)
1998 - 2001
University of Melbourne
Juris Doctor (Law)
2010 - 2015
TRIUM Global Executive MBA
Executive MBA
2005 - 2007
The London School of Economics and Political Science (LSE)
TRIUM Global Executive MBA
2005 - 2007
New York University - Leonard N. Stern School of Business
TRIUM Global Executive MBA
2005 - 2007
HEC Paris
TRIUM Global Executive MBA
2005 - 2007
Stanford University School of Medicine
Graduate Diploma in Bioinformatics
2005 - 2006
Monash University
Bachelor of Engineering
1995 - 1997
University of Melbourne
Bachelor of Engineering / Bachelor of Science
1992 - 1994
Chris Behrenbruch's Skills
Biotechnology
Start Ups
Entrepreneurship
Venture Capital
Business Development
Lifesciences
Business Strategy
Technology Transfer
Mergers and Acquisitions
Product Development
Chris Behrenbruch's Summary
Chris Behrenbruch, based in Melbourne, VIC, AU, is currently a CEO and Managing Director at Telix Pharmaceuticals Limited, bringing experience from previous roles at Factor Therapeutics Ltd, Amplia Therapeutics and Monash University. Chris Behrenbruch holds a 1998 - 2001 Ph.D (D.Phil) @ University of Oxford. With a robust skill set that includes Biotechnology, Start Ups, Entrepreneurship, Venture Capital, Business Development and more, Chris Behrenbruch contributes valuable insights to the industry. Chris Behrenbruch has 3 emails on RocketReach.